Bank of America’s Acer Therapeutics Inc ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26
Closed -$66 8467
2022
Q4
$66 Buy
+26
New +$45 ﹤0.01% 7752
2022
Q1
Sell
-18
Closed 8966
2021
Q4
$0 Buy
+18
New +$42 ﹤0.01% 8823
2021
Q3
Sell
-52
Closed 8507
2021
Q2
$0 Buy
+52
New +$150 ﹤0.01% 8222
2020
Q4
Sell
-3
Closed 7458
2020
Q3
$0 Sell
3
-3,580
-100% -$11.6K ﹤0.01% 7278
2020
Q2
$12K Buy
3,583
+3,430
+2,242% +$9.68K ﹤0.01% 6399
2020
Q1
$0 Sell
153
-487
-76% -$1.78K ﹤0.01% 7369
2019
Q4
$3K Sell
640
-503
-44% -$1.71K ﹤0.01% 6854
2019
Q3
$4K Buy
1,143
+147
+15% +$431 ﹤0.01% 6909
2019
Q2
$4K Sell
996
-1,717
-63% -$32.7K ﹤0.01% 6881
2019
Q1
$66K Buy
+2,713
New +$64K ﹤0.01% 6085
2018
Q2
Sell
-419
Closed -$8K 7395
2018
Q1
$8K Buy
419
+407
+3,392% +$7.46K ﹤0.01% 6680
2017
Q4
$0 Buy
+12
New +$195 ﹤0.01% 7323
2017
Q1
Sell
-29
Closed 7311
2016
Q4
$0 Buy
29
+28
+2,800% +$490 ﹤0.01% 7408
2016
Q3
$0 Buy
+1
New +$42 ﹤0.01% 7430
2016
Q2
Hold
0
7463
2015
Q3
Sell
-22
Closed -$1K 7476
2015
Q2
$1K Buy
+22
New +$846 ﹤0.01% 7154
2014
Q3
Sell
-3
Closed 8225
2014
Q2
$0 Buy
+3
New +$397 ﹤0.01% 8266
2014
Q1
Sell
-49
Closed -$7K 8166
2013
Q4
$7K Buy
+49
New +$7.97K ﹤0.01% 7401

Other funds holding ACER

Bank of America's ACER Position: Q1 2023 in Review

Bank of America sold out of Acer Therapeutics Inc (ACER) in Q1 2023, closing a stake of 26 shares — an estimated $66 sold.

Bank of America first reported a position in ACER in Q4 2013 and held it in 17 quarters. The position peaked at $66K in Q1 2019. 27 funds tracked by Wall St. Rank hold ACER as of Q1 2023.

  • Bank of America reported no remaining Acer Therapeutics Inc position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 26 Acer Therapeutics Inc shares in Q1 2023, an estimated $66.
  • Bank of America first reported a position in Acer Therapeutics Inc in Q4 2013 and held it in 17 quarters.
  • Bank of America's Acer Therapeutics Inc position peaked at $66K in Q1 2019.
  • 27 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.